Author

P. Czarnewski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:clustering· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Emmanouilidi· 1 shared A. M. Harandi· 1 shared C. Lebrero-Fernandez· 1 shared C. Sorini· 1 shared D. Angeletti· 1 shared E. J. Villablanca· 1 shared H. Axelsson· 1 shared I. Smirnov· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Emmanouilidi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell BCR and transcriptome analysis after respiratory virus infection reveals spatiotemporal dynamics of antigen-specific B cell responses.

N. R. Mathew, J. K. Jayanthan, I. Smirnov, J. L. Robinson, H. Axelsson, S. S. Nakka, A. Emmanouilidi, P. Czarnewski, W. T. Yewdell, C. Lebrero-Fernandez, V. Bernasconi, A. M. Harandi, N. Lycke, N. Borcherding, J. W. Yewdell, , D. Angeletti

The paper analyzes single-cell BCR and transcriptome data from influenza-infected mice to reveal organ-specific B cell dynamics and clonal responses.

bioRxiv · Aug 24, 2020Immunology

Conserved transcriptomic profile between mouse and human colitis allows temporal dynamic visualization of IBD-risk genes and unsupervised patient stratification

P. Czarnewski, S. M. Parigi, C. Sorini, O. E. Diaz, S. Das, N. Gagliani, E. J. Villablanca

This study uses cross-species transcriptomic data to identify temporal dynamics of IBD-risk genes and stratify UC patients into two subgroups with distinct therapeutic responses.

bioRxiv · Jan 16, 2019Immunology